Jun 14, 2026 02:01PM
Jun 13, 2026 06:33AM
Jun 11, 2026 07:45AM
Jun 11, 2026 07:45AM
Jun 11, 2026 07:43AM
Jun 11, 2026 02:03AM
Jun 11, 2026 02:03AM IMAAVY® (nipocalimab-aahu) demonstrates durable hemoglobin response and rapid onset of effect in pivotal Phase 2/3 study in warm autoimmune hemolytic anemia (wAIHA), an autoantibody-driven disease wi
Jun 3, 2026 03:14AM
Jun 3, 2026 12:04AM
Jun 3, 2026 12:04AM
Jun 3, 2026 12:03AM
May 31, 2026 08:29AM
May 31, 2026 08:28AM
May 31, 2026 08:27AM Johnson & Johnson's Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, breaking a decades-long treatment paradi
May 29, 2026 02:00PM
May 29, 2026 02:00PM
May 29, 2026 08:41AM
May 29, 2026 08:18AM
May 28, 2026 07:10PM
May 28, 2026 07:10PM
May 15, 2026 02:58PM FDA approves accord Biopharma's Immgolis, a biosimilar to Simponi
May 13, 2026 08:30AM
May 11, 2026 08:01AM
May 11, 2026 08:00AM
May 5, 2026 08:05AM
May 5, 2026 08:05AM
May 5, 2026 08:05AM
May 5, 2026 08:05AM Johnson & Johnson study shows TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to demonstrate efficacy in perianal fistulizing Crohn's disease
May 5, 2026 07:00AM
May 5, 2026 07:00AM
May 4, 2026 08:03AM
May 4, 2026 08:00AM
Apr 27, 2026 08:03AM
Apr 27, 2026 08:03AM
Apr 24, 2026 08:38AM Johnson & Johnson to acquire medical device firm Atraverse Medical
Apr 22, 2026 08:07AM
Apr 22, 2026 08:05AM
Apr 16, 2026 11:00AM
Apr 15, 2026 07:21AM
Apr 14, 2026 06:20AM
Apr 10, 2026 08:01AM
Apr 10, 2026 08:00AM Johnson & Johnson Showcases New Clinical Data for TECNIS PureSee IOL at ASCRS 2026 Demonstrating Excellent Contrast Sensitivity and Extended Range of Vision
Apr 9, 2026 08:30AM
Apr 1, 2026 12:52PM
Mar 30, 2026 04:21AM
Mar 28, 2026 10:00AM
Mar 23, 2026 07:45AM
Mar 19, 2026 06:33AM
Mar 18, 2026 11:23AM Morgan Stanley stays Overweight on Johnson & Johnson (JNJ) following 'expected positive' Ico approval
Mar 18, 2026 08:43AM

323,123 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All